Skip to main content
Ray Page, DO, Oncology, Fort Worth, TX, Baylor Scott & White All Saints Medical Center - Fort Worth

RayPageDOPhD

Oncology Fort Worth, TX

President, The Center for Cancer and Blood Disorders

Dr. Page is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Page's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
  • Osteopathic Medical Center of Texas
    Osteopathic Medical Center of TexasResidency, Internal Medicine, 1991 - 1994
  • University of North Texas
    University of North TexasPhD, Biology (Pharmacology), 1986 - 1991
  • Texas College of Osteopathic Medicine
    Texas College of Osteopathic MedicineClass of 1991
  • Baylor College of Dentistry
    Baylor College of DentistryMS, Physiology, 1984 - 1986
  • Baylor University Graduate School , Baylor College of Dentistry
    Baylor University Graduate School , Baylor College of DentistryMSc, Physiology, 1984 - 1986
  • Southwestern University
    Southwestern UniversityB.S., Chemistry and Biology, 1980 - 1984

Certifications & Licensure

  • TX State Medical License
    TX State License 1992 - 2025
  • AOA Board of Internal Medicine Oncology

Awards, Honors, & Recognition

  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
  • Distinguished Alumnus Grand Prairie High School, 2010
  • Outstanding Preceptor of the Year Physician Assistant Program, UNTHSC, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Breast Cancer International Research Group. Adjuvant trastuzumab in HER2-positive breast cancer.  
    Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F..., N Engl J Med, 10/1/2011
  • A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell...  
    Blumenschein GR Jr, Kabbinavar F, Menon H, Mok TS, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L; Motesanib NSCL..., Ann Oncol, 9/1/2011
  • Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.  
    Coiffier B, Osmanov EA, Hong X, et. al, Lancet Oncol, 8/1/2011
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Medicare 2005 Demonstration Project: Patient reporting of nausea symptoms and its impact on improving quality of patient care.
    Mueller, B. and Page, R.D., ASCO Proceedings, 1/1/2007
  • Prospective multi-center phase II trial of dose dense docetaxel and vinorelbine with filgrastim support in subjects with advanced non-small-cell lung cancer (NSCLC).
    Page, R.D., Smith, G.F., Beall, C.L., Ross, M.B., et. al., ASCO Proceedings, 1/1/2004
  • A multicenter web-based Phase III study to test the survival equivalence of a non-platinum based versus a platinum-based therapy for advanced non-small cell lung cance...
    Rigas, J., Carey, M., Cole, B., Evans, A., Page, R.D., et. al., ASCO Proceedings, 1/1/2004
  • Join now to see all

Lectures

  • "Experience with Via OncologyTreatment Pathways in Community Practice" 
    Fox-Chase Cancer Center, Philadelphia, PA - 12/1/2011
  • "Prostate Cancer Update" 
    Fort Worth, Tx - 11/1/2011
  • "Cancer Prevention and Early Detection" 
    Fort Worth, Tx - 11/1/2011
  • Join now to see all

Other

  • New Guidelines for the Screening of Cervical Cancer. 
    McClennen, R., Wiggins, J., Page, R.D., Texas D.O.
    10/1/2003
  • Medical Oncology Fellows Home Page (Worl Wide Web/Internet) 
    Page, R.D.
    http://mda.uth.tmc.edu
    1/1/1996
  • Hyperthyroidism: Physical Examination findings. (Audio Visual Presentation) 
    Page, R.D., TCOM LC Files
    1/1/1993
  • Join now to see all

Press Mentions

  • In Growth Spurt Since Joining OneOncology, the Center for Cancer and Blood Disorders in Fort Worth Adds 3 Practices and 14 Physicians
    In Growth Spurt Since Joining OneOncology, the Center for Cancer and Blood Disorders in Fort Worth Adds 3 Practices and 14 PhysiciansJuly 12th, 2021
  • Artificial Intelligence in Oncology Care Saved $3 Million for One Texas Provider
    Artificial Intelligence in Oncology Care Saved $3 Million for One Texas ProviderNovember 19th, 2020
  • Hurry up and Wait: Docs Say Insurers Increasingly Interfere
    Hurry up and Wait: Docs Say Insurers Increasingly InterfereJuly 29th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations